Cell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade or lymph node status (Q74126218)
Jump to navigation
Jump to search
scientific article published on 01 April 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade or lymph node status |
scientific article published on 01 April 2000 |
Statements
Cell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade or lymph node status (English)
J L Mccoy
R Rucker